- Reported transaction lines
- 1
- Buy lines
- 0
- Sell lines
- 0
Filing activity by month
Original filing lines in up to 12 months with activity.
- 2026-111
Frequently disclosed stocks
Disclosure history
| Reporting investor | Security | Activity | Transaction / period | Filed | Reported amount | Source |
|---|---|---|---|---|---|---|
| Nova Tina Susan Director · EXAGEN INC. | XGN EXAGEN INC. | Equity grant or awardFiling detailsSEC transaction code A Stock Option(right to buy) · Derivative security · Direct ownership · Reported balance after transaction: 137313 · The entire number of shares subject to this option becomes fully vested and exercisable on the first to occur of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date. | 2026-06-09 | 2026-11-02 | 56,200 shares/units | SEC 4 |
Counts describe original filing lines in BriefStock’s coverage. Later amendments can correct or supplement them. Check the original filing for ownership and transaction details.